Actively Recruiting

Age: 18Years - 90Years
All Genders
NCT05476523

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Led by NeuraLight · Updated on 2025-05-20

2000

Participants Needed

1

Research Sites

231 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is an observational prospective study in a cohort of healthy subjects who are enrolled using convenience and snowballing sampling. The aims of the study is to demonstrate the efficacy of using NeuraLight system to capture oculometric data from healthy participants and to validate the data capture of NeuraLight oculometric measurements as compared with a validated eye-tracker system in subjects who meet the inclusion criteria and who provide a signed Informed Consent.

CONDITIONS

Official Title

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Who Can Participate

Age: 18Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women ages between 18 and 90 years old
  • Normal or corrected vision
  • Ability to follow instructions
  • Willing and able to sign an informed consent form
Not Eligible

You will not qualify if you...

  • Inability to sit for 20 minutes on a chair in a calm manner
  • Personal or 1st degree relative history of epilepsy
  • Additional neurological diseases
  • Drug or alcohol abuse

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

NeuraLight

Wilmington, Delaware, United States, 19801

Actively Recruiting

Loading map...

Research Team

E

Eitan Raveh, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here